Financiere de Tubize (STU:FTD) Net Margin %: 0.00% (As of Dec. 2025)


STU:FTD Financiere de Tubize SA STU:FTD
38 GF Score
Price €219.00
! 2 Warning Signs
View Full Analysis

What is Financiere de Tubize Net Margin %?

Financiere de Tubize STU:FTD +1.01% 38 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates STU:FTD with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Financiere de Tubize ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Financiere de Tubize's Net Income for the six months ended in Dec. 2025 was €-2.34 Mil. Financiere de Tubize's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Financiere de Tubize's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Financiere de Tubize's Net Margin % or its related term are showing as below:


STU:FTD's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Financiere de Tubize  (STU:FTD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Financiere de Tubize Net Margin % Related Terms

Financiere de Tubize Net Margin % Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize Net Margin % Chart

Financiere de Tubize Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Financiere de Tubize Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:FTD vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Financiere de Tubize's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Financiere de Tubize Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's Net Margin % distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's Net Margin % falls into.


STU:FTD
38GF Score
Financiere de Tubize SA STU:FTD
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Financiere de Tubize's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=93.228/0
= %

Financiere de Tubize's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.344/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Financiere de Tubize (STU:FTD) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Financiere de Tubize and its competitors. Over the past decade, Financiere de Tubize's Net Margin % has ranged from 9,456,800.00 to 9,456,800.00. According to the industry distribution chart, Financiere de Tubize ranks #999999 out of 946 companies in the Biotechnology industry.
Is Financiere de Tubize's Net Margin % too high?
Financiere de Tubize's current Net Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9,456,800.00 to a high of 9,456,800.00. Based on the distribution chart, Financiere de Tubize ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Financiere de Tubize has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Financiere de Tubize ranks #999999 out of 946 companies for Net Margin %. This places Financiere de Tubize in the lower half of its industry. Historically, Financiere de Tubize's own Net Margin % has ranged from 9,456,800.00 to 9,456,800.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Financiere de Tubize and its competitors. Financiere de Tubize's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (STU:FTD) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Financiere de Tubize's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Financiere de Tubize (STU:FTD), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
38GF Score

Get the complete analysis for STU:FTD

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€219.00
Price